Hoth Therapeutics Says FDA Accepts IND Application For HT-001 For Treatment Of Cancer Disorders

RTTNews | 1037 dias atrás
Hoth Therapeutics Says FDA Accepts IND Application For HT-001 For Treatment Of Cancer Disorders

(RTTNews) - Biopharmaceutical company Hoth Therapeutics, Inc. (HOTH) announced Thursday that the U.S. Food and Drug Administration (FDA) has accepted an Investigational New Drug (IND) application for the company's HT-001 therapeutic for the treatment for rash and skin disorders associated with epidermal growth factor receptor (EGFR) inhibitor therapy.

EGFR inhibitors are critical therapeutic agents for the treatment of non-small cell lung cancer (NSCLC), pancreatic cancer, colorectal cancer, squamous-cell carcinoma of the head and neck, and breast cancer.

The company said this trial brings us one step closer to a new treatment option for underserved cancer patients as there is no specific treatment currently approved for the treatment of skin toxicities associated with EGFRi therapies.

The company added it will advance HT-001 into the clinical phase as it is a key treatment in the onco-dermatology space and anticipates beginning the Phase 2a trial in the first quarter of 2023.

Marcadores : HOTH
read more
Hoth Therapeutics' Pre-IND Submission For HT-KIT For Advance Systemic Mastocytosis Accepted By FDA

Hoth Therapeutics' Pre-IND Submission For HT-KIT For Advance Systemic Mastocytosis Accepted By FDA

Biopharmaceutical company Hoth Therapeutics, Inc. (HOTH) announced Monday it has submitted a request for a Pre-Investigational New Drug (IND) meeting to the U.S. Food and Drug Administration (FDA) to discuss the proposed drug development program for HT-KIT, a new molecular entity, for the treatment of advance systemic mastocytosis (AdvSM), a rare aggressive form of cancer.
RTTNews | 781 dias atrás
Swiss Market Settles Moderately Lower

Swiss Market Settles Moderately Lower

The Switzerland market ended weak on Friday, in line with markets across Europe, as investors chose to trim down positions at several counters, continuing to react to earnings updates and assessing the developments on the trade front.
RTTNews | 38 minutos atrás
European Markets Close Weak After Cautious Session

European Markets Close Weak After Cautious Session

European markets closed weak on Friday, as investors reacted to a slew of earnings updates, regional economic data, and continued to assess the recent policy announcements from major central banks, and the developments on the trade front.
RTTNews | 1h 2min atrás
Chicago Business Barometer Climbs More Than Expected But Still Indicates Contraction

Chicago Business Barometer Climbs More Than Expected But Still Indicates Contraction

A reading on Chicago-area business activity increased by more than expected in the month of October but continued to indicate contraction, according to a report released by MNI Indicators on Friday. The report said the Chicago business barometer climbed to 43.8 in October after slipping to 40.6 in September. Economists had expected the index to show a more modest increase to 42.3.
RTTNews | 4h 45min atrás
Eurozone Inflation Softens On Energy Prices

Eurozone Inflation Softens On Energy Prices

Eurozone inflation softened in October largely due to the fall in energy prices, while core consumer prices registered a steady growth, official data revealed Friday. The harmonized index of consumer prices rose 2.1 percent on a yearly basis, following a 2.2 percent rise in September, flash estimate from Eurostat showed. Inflation came in line with expectations.
RTTNews | 5h 22min atrás